文献速递母胎医学产科

中覆盖度全基因组测序用于胎儿结构异常的产前诊断:与染色体微阵列分析在3973例妊娠中的大规模比较研究

Prenatal Diagnosis of Foetal Structural Anomalies Using Medium-Coverage Whole Genome Sequencing (CMA-Seq): A Large-Scale Comparative Study With CMA in 3973 Pregnancies.
PubMed 文献 · BJOG · 2025-05-23

前瞻性临床研究纳入3973例超声检出胎儿结构异常或其他高危指征的孕妇,经羊膜腔穿刺行中覆盖度全基因组测序(CMA-seq),并与传统染色体微阵列分析(CMA)进行系统Meta分析比较。CMA-seq检出染色体异常982/3973(24.72%),低比例嵌合非整倍体42例、小于100 kb的拷贝数变异40例、杂合性缺失112例(2.82%);Meta分析显示传统CMA的合并嵌合染色体检出率为1.10%、小于500 kb的拷贝数变异比例为2.06%、杂合性缺失检出率为1.26%。结论认为CMA-seq在检测低水平嵌合非整倍体、小片段拷贝数变异和杂合性缺失方面具有更高的敏感性。

要点

  • CMA-seq在3973例产前样本中检出染色体异常24.72%(982/3973)。
  • CMA-seq检出嵌合非整倍体占样本6.5%(42例低于30%嵌合),小于100 kb的拷贝数变异40例。
  • 传统CMA的Meta分析合并嵌合染色体检出率1.10%、小于500 kb拷贝数变异比例2.06%、杂合性缺失检出率1.26%。

核心结论

  • CMA-seq在检测低水平嵌合非整倍体、小片段拷贝数变异和杂合性缺失方面较传统CMA具有更高的敏感性。

研究设计与样本

  • 前瞻性临床研究,纳入3973例超声检出胎儿结构异常或其他高危指征的孕妇,经羊膜腔穿刺采集标本行CMA-seq检测。
  • 同时进行系统Meta分析,检索中英文数据库筛选临床研究,评估传统CMA在产前诊断中的应用与效果。

主要发现

  • CMA-seq检出染色体异常982/3973(24.72%)。
  • 嵌合非整倍体检出占样本6.5%,其中42例嵌合比例低于30%。
  • 共670例检出拷贝数变异,其中40例小于100 kb。
  • 杂合性缺失检出112例(2.82%)。
  • Meta分析显示传统CMA的合并嵌合染色体检出率为1.10%、小于500 kb的拷贝数变异比例为2.06%、杂合性缺失检出率为1.26%。

关键数值与推荐

  • CMA-seq检出染色体异常24.72%(982/3973)。
  • 嵌合非整倍体占样本6.5%,其中42例嵌合比例低于30%。
  • 拷贝数变异670例,其中小于100 kb者40例;杂合性缺失112例(2.82%)。
  • 传统CMA的Meta分析:合并嵌合染色体检出率1.10%,小于500 kb拷贝数变异比例2.06%,杂合性缺失检出率1.26%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the feasibility and effectiveness of medium-coverage whole genome sequencing (CMA-seq) for prenatal diagnosis of foetal structural anomalies, and to compare its performance with conventional chromosomal microarray analysis (CMA). DESIGN: A prospective clinical study combined with a systematic meta-analysis. SETTING: A tertiary maternal and child health hospital in Chongqing, China. POPULATION OR SAMPLE: 3973 pregnant women with ultrasound-detected foetal structural anomalies or other high-risk indications. METHODS: Specimens were collected through amniocentesis, followed by CMA-seq to identify a wide range of chromosomal abnormalities. Meta-analysis was used to study the application and effectiveness of CMA in prenatal diagnosis. Clinical studies were screened in Chinese and English databases, and a meta-analysis was performed. MAIN OUTCOME MEASURES: Detection rates for chromosomal abnormalities, including mosaic aneuploidy, small copy number variants (CNVs < 100 kb) and absence of heterozygosity. RESULTS: CMA-seq identified chromosomal abnormalities in 24.72% (982/3973) of cases. Mosaic aneuploidy was detected in 6.5% of samples (42 cases < 30% mosaicism). A total of 670 cases were presented with CNVs, including 40 below 100 kb. AOH was found in 112 cases (2.82%). The meta-analysis indicated a lower pooled chimeric chromosome detection rate (1.10%), a smaller proportion of CNVs < 500 kb (2.06%), and reduced AOH detection (1.26%) with conventional CMA. CONCLUSION: CMA-seq exhibits significant advancements and superior sensitivity in detecting low-level mosaic aneuploidy, small segment CNVs and AOH.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Jiang Y, Liu F, Zhong L, et al. Prenatal Diagnosis of Foetal Structural Anomalies Using Medium-Coverage Whole Genome Sequencing (CMA-Seq): A Large-Scale Comparative Study With CMA in 3973 Pregnancies. BJOG. 2025. PMID: 40406936. doi:10.1111/1471-0528.18222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。